Hyderabad-based vaccine manufacturer Bharat Biotech announced on April 24 that its COVID-19 vaccine Covaxin will be sold at Rs 600 per dose to states and Rs 1,200 per dose to private hospitals during the third phase of India’s coronavirus vaccination drive.
“Following the Govt of India directives, we announce the prices of COVAXIN vaccines – Rs 600 per dose for state hospitals and Rs 1,200 per dose for private hospitals,” Bharat Biotech said in a statement.
Bharat Biotech further announced that it would also export Covaxin, and the export price of the COVID vaccine would be between $15-$20, i.e., between Rs 1,100 to Rs 1,500 approximately.
Stating that it is “deeply concerned” about the current COVID-19 situation in India and the rest of the world, the company said: “Bharat Biotech is honored to develop, manufacture, and supply Covaxin for India’s vaccine rollout at Rs 150 per dose, which is distributed for free by the Government of India. We want to state that more than 50 per cent of our capacities have been reserved for central government supplies.”
SII will also be reserving 50 per cent of its capacity to support India’s vaccination programme.
